| 000 | 01732 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513195949.0 | ||
| 264 | 0 | _c19991220 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a0364-5134 | ||
| 024 | 7 |
_a10.1002/1531-8249(199912)46:6<850::aid-ana7>3.0.co;2-q _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiller, D H | |
| 245 | 0 | 0 |
_aEffect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secondary progressive multiple sclerosis. _h[electronic resource] |
| 260 |
_bAnnals of neurology _cDec 1999 |
||
| 300 |
_a850-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBrain _xpathology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 | _aInterferon beta-1b |
| 650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aMolyneux, P D | |
| 700 | 1 | _aBarker, G J | |
| 700 | 1 | _aMacManus, D G | |
| 700 | 1 | _aMoseley, I F | |
| 700 | 1 | _aWagner, K | |
| 773 | 0 |
_tAnnals of neurology _gvol. 46 _gno. 6 _gp. 850-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1531-8249(199912)46:6<850::aid-ana7>3.0.co;2-q _zAvailable from publisher's website |
| 999 |
_c10545695 _d10545695 |
||